Summary
- Current Price
- As of today, GTBP price is $8.61, up +39.32% on
- Current Price All-Time High
- GTBP price is currently -99.40% below its historical high of $1,428.00 set on
- Market Cap
- GTBP current market cap is $16M, up +15830.71% over the past 365 days
- Revenue
- GTBP current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for GTBP has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | GT Biopharma, Inc. |
| Ticker | NASDAQ: GTBP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | gtbiopharma.com |
| Employees | 1 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $8.61 | ||
| Price, 1D Change | +39.32% | |
| $16M | ||
| - | ||
| - | ||
| -5.68 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$156.21 | ||
| EPS, 1Y Change | +9.93% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:25 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$156.21 | ||
| EPS Estimate | -$10.75 | N/A |
| EPS Est. Change | +93.12% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $8.61 | ||
| Price Target | $75.00 | - |
| Price Tgt. Change | +771.08% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$10.80 | -$173.42 | -1,505.78% | |
| -$1.66 | -$156.21 | -9,310.24% | |
| -$10.75 | N/A | +93.12% | |
| -$8.00 | N/A | +94.88% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| +1,055.70% | ||
| +14.80% | ||
| +15,830.71% | ||
| +3,721.82% | ||
| 0.00% | ||
| 0.00% | ||
| +9.93% | ||
| +68.22% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $8.61 | ||
| $0.57 | ||
| $0.73 | ||
| $0.78 | ||
| $1.08 | ||
| $1.28 | ||
| -5.68 | ||
| $0.66 | ||
| 98.80 | ||
| 11.94% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $229.00K | ||
| -0.81% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$156.21 | ||
| $0.00 | ||
| - | ||
| -$12.42M | ||
| - | ||
| -$28.35M | ||
| - | ||
| -$12.42M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 3.22 | ||
| 3.22 | ||
| - | ||
| - | ||
| -125.30 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 4.35 | ||
| -0.64 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $5.79M | ||
| $6.91M | ||
| $8.11M | ||
| $7.47M | ||
| $2.32M | ||
| $2.32M | ||
| $0.00 | ||
| $0.00 | ||
| $748.00K |
Expenses
| Metric | Value | Date |
|---|---|---|
| $28.35M | ||
| $12.42M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$12.91M | ||
| $0.00 | ||
| $15.78M | ||
| $0.00 | ||
| -$12.91M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Roth MKM | ||
| HC Wainwright & Co. | → | |
| EF Hutton | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| EF Hutton | → | |
| HC Wainwright & Co. | ||
| EF Hutton | ||
| EF Hutton | ||
| HC Wainwright & Co. |
Analyst sentiment
Institutional ownership
Screeners with GTBP
FAQ
- What is the ticker symbol for GT Biopharma, Inc.?
- The ticker symbol for GT Biopharma, Inc. is NASDAQ:GTBP
- Does GT Biopharma, Inc. pay dividends?
- No, GT Biopharma, Inc. does not pay dividends
- What sector is GT Biopharma, Inc. in?
- GT Biopharma, Inc. is in the Healthcare sector
- What industry is GT Biopharma, Inc. in?
- GT Biopharma, Inc. is in the Biotechnology industry
- What country is GT Biopharma, Inc. based in?
- GT Biopharma, Inc. is headquartered in United States
- When did GT Biopharma, Inc. go public?
- GT Biopharma, Inc. initial public offering (IPO) was on March 27, 2018
- Is GT Biopharma, Inc. in the S&P 500?
- No, GT Biopharma, Inc. is not included in the S&P 500 index
- Is GT Biopharma, Inc. in the NASDAQ 100?
- No, GT Biopharma, Inc. is not included in the NASDAQ 100 index
- Is GT Biopharma, Inc. in the Dow Jones?
- No, GT Biopharma, Inc. is not included in the Dow Jones index
- When was GT Biopharma, Inc. last earnings report?
- GT Biopharma, Inc.'s most recent earnings report was on May 13, 2024
- When does GT Biopharma, Inc. report earnings?
- The date for GT Biopharma, Inc.'s next earnings report has not been announced yet
Data Sources & References
- GTBP Official Website www.gtbiopharma.com
- GTBP Profile on Yahoo Finance finance.yahoo.com/quote/GTBP
- GTBP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gtbp